SABS
SAB Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
SABS Filings
Filing Date
Form Description
Form Type
2025-12-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-12 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-10-03
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-03 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-03
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-10-03 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-10-03
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-03 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-01
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-01 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-01
Form EFFECT - Notice of Effectiveness
2025-10-01 ·
Form EFFECT - Notice of Effectiveness
